VRDN · Viridian Therapeutics, Inc.\DE
Market Cap
$2.60B
Shares
113.29M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Stephen Mahoney | Chief Executive Officer | $6,776,249 |
| Radhika Tripuraneni | — | $4,080,466 |
| Thomas Beetham | Chief Operating Officer | $3,761,182 |
| Seth Harmon | Chief Financial Officer | $2,642,779 |
| Jennifer Tousignant | Chief Legal Officer | $2,351,915 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jennifer Tousignant | Chief Legal Officer | $4,911,024 |
| Dr. Barrett Katz | Former Chief Medical Officer | $2,160,823 |
| Dr. Thomas Ciulla | Chief Medical Officer | $1,610,609 |
| Stephen Mahoney | Chief Executive Officer | $1,117,454 |
| Thomas Beetham | Chief Operating Officer | $809,500 |
| Seth Harmon | Senior Vice President, Finance and Accounting | $770,659 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Scott D. Myers | CEO | $36,407,990 |
| Scott Myers | Former President, Chief Executive Officer and Director | $36,407,990 |
| Stephen Mahoney | Chief Executive Officer | $12,479,521 |
| Dr. Thomas Ciulla | Chief Medical Officer | $10,646,112 |
| Seth Harmon | Senior Vice President, Finance and Accounting | $6,548,526 |
| Thomas Beetham | Chief Operating Officer | $4,761,402 |
| Dr. Barrett Katz | Former Chief Medical Officer | $3,275,999 |
| Jonathan Violin | Former President, Chief Executive Officer and Director | $2,211,072 |
| Jennifer Tousignant | Chief Legal Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jonathan Violin | Former President, Chief Executive Officer and Director | $4,646,740 |
| Barrett Katz | Chief Medical Officer | $2,110,655 |
| Dr. Barrett Katz | Former Chief Medical Officer | $2,110,655 |
| Kristian Humer | Chief Financial and Business Officer | $2,023,780 |
| Dr. Thomas Ciulla | Chief Medical Officer | — |
| Stephen Mahoney | Chief Executive Officer | — |
| Jennifer Tousignant | Chief Legal Officer | — |
| Seth Harmon | Senior Vice President, Finance and Accounting | — |
| Thomas Beetham | Chief Operating Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jonathan Violin | Former President, Chief Executive Officer and Director | $17,408,538 |
| Barrett Katz | Chief Medical Officer | $8,167,089 |
| Kristian Humer | Chief Financial and Business Officer | $7,708,958 |
| Lee Rauch | Former President and Chief Executive Officer and Director | $1,779,054 |
| Dr. Thomas Ciulla | Chief Medical Officer | — |
| Jennifer Tousignant | Chief Legal Officer | — |
| Thomas Beetham | Chief Operating Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| William S. Marshall | Former President and Chief Executive Officer | $2,186,819 |
| Lee Rauch | Former President and Chief Executive Officer and Director | $1,670,411 |
| Diana Escolar | Former Chief Medical Officer | $865,618 |
| Jason Leverone | Chief Financial Officer, Treasurer, and Secretary | $483,020 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| William S. Marshall | Former President and Chief Executive Officer | $1,075,942 |
| Paul D. Rubin | Former Executive Vice President, Research and Development | $632,738 |
| Diana Escolar | Former Chief Medical Officer | $550,005 |
| Jason Leverone | Chief Financial Officer, Treasurer, and Secretary | $537,807 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| William S. Marshall | President and Chief Executive Officer | $1,987,005 |
| Paul D. Rubin | Former Executive Vice President, Research and Development | $976,769 |
| Jason Leverone | Chief Financial Officer | $824,667 |
Key facts
CIK
1590750
CUSIP
92790C104
13F (30d)
174 filings
174 filers
Visit website
Investor relations